Table 2.

Univariate analysis of FFBF by multiple variables.

		1-year (%)	2-year (%)	3-year (%)	4-year (%)	5-year (%)	p-Value
All patients	n = 270	99.6	99.6	97.7	95.4	92.2
Age	≤69a	99.3	99.3	95.5	94.5	93.2	0.8337
	>69a	100.0	100.0	100.0	96.4	91.2
Treatment	SBRT	100.0	100.0	98.2	97.1	92.0	0.4608
	IMRT	99.2	99.2	97.1	93.6	92.2
Risk group	Very low	100.0	100.0	100.0	100.0	100.0	0.0032
	Low	100.0	100.0	100.0	100.0	95.7
	Int.	100.0	100.0	98.3	96.5	94.2
	High	100.0	100.0	96.5	94.5	89.7
	Very high	94.4	94.4	87.2	72.7	72.7
Pre-tx PSA	<10	100.0	100.0	98.8	96.7	94.6	0.0083
	10–20	100.0	100.0	100.0	100.0	86.3
	>20	95.5	95.5	83.9	77.9	77.9
T-stage	T1c/T2a	100.0	100.0	99.3	97.0	93.0	0.1184
	T2B/T2C	100.0	100.0	94.4	92.2	89.8
	T3a	83.3	83.3	83.3	83.3	.
Gleason score	5–6	100.0	100.0	98.8	98.8	96.5	0.0199
	7	100.0	100.0	98.8	96.2	91.1
	8+	97.1	97.1	90.1	82.4	82.4
ADT	No ADT	100.0	100.0	98.1	98.1	92.4
	ADT	99.2	99.2	97.2	92.8	91.4	0.2394

^aMedian.